September 6th, 09:00-18:00, room 910, Kimmel Center, 60 Washington Square South, ·New York University ·NYC ·USA (Building 45 on map)
Multiple Sclerosis is an inflammatory and demyelinating disease that exhibits regions with high demyelinating activity shown as focal lesions on MRI that usually affects young adults. Even in normal appearing brain tissues (NABT) there are alterations often not visible on conventional MRI sequences. While MRI has a low specificity for differentiating between possible pathological changes which could aid in discriminating between the different lesion types, it has a high sensitivity to detect focal and also widespread, diffuse pathology of the normal appearing white and grey matter. The objective of medical image analysis procedures is to define new neuroimaging biomarkers to track the evolution of the pathology from high dimensional data. This workshop will give an overview of new advances of medical image acquisition and analysis in Multiple Sclerosis.
The objective of this workshop is to bring together researchers in medical image analysis, biologists, radiologists and neurologists working in the field of neuroimaging biomarkers in MS. These methods are key for a better understanding of the different stages of the disease, for a better modelling of the natural history of the pathology, and for efficacy studies in clinical trials.
We solicit papers that use methods of medical image analysis methods in the following domains:
Christian BARILLOT Unit/Project VisAGeS - U746 INSERM/INRIA, IRISA, CNRS 6074, Univ. of Rennes1, Rennes, France
D. Louis COLLINS McConnell Brain Imaging Center, Montreal Neurological Institute, QC, CANADA